A Compressive Review about Taxol®: History and Future Challenges

J Gallego-Jara, G Lozano-Terol, RA Sola-Martínez… - Molecules, 2020 - mdpi.com
Taxol®, which is also known as paclitaxel, is a chemotherapeutic agent widely used to treat
different cancers. Since the discovery of its antitumoral activity, Taxol® has been used to …

LncRNAs in ovarian cancer progression, metastasis, and main pathways: ceRNA and alternative mechanisms

EA Braga, MV Fridman, AA Moscovtsev… - International journal of …, 2020 - mdpi.com
Ovarian cancer (OvCa) develops asymptomatically until it reaches the advanced stages with
metastasis, chemoresistance, and poor prognosis. Our review focuses on the analysis of …

Role of non-coding RNAs and RNA modifiers in cancer therapy resistance

X Zhang, K Xie, H Zhou, Y Wu, C Li, Y Liu, Z Liu, Q Xu… - Molecular cancer, 2020 - Springer
As the standard treatments for cancer, chemotherapy and radiotherapy have been widely
applied to clinical practice worldwide. However, the resistance to cancer therapies is a major …

[HTML][HTML] Current trends in drug metabolism and pharmacokinetics

Y Li, Q Meng, M Yang, D Liu, X Hou, L Tang… - … Pharmaceutica Sinica B, 2019 - Elsevier
Pharmacokinetics (PK) is the study of the absorption, distribution, metabolism, and excretion
(ADME) processes of a drug. Understanding PK properties is essential for drug development …

Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer

W Xie, M Chu, G Song, Z Zuo, Z Han, C Chen… - Seminars in cancer …, 2022 - Elsevier
Pancreatic cancer is one of the most common causes of cancer death in the world due to the
lack of early symptoms, metastasis occurrence and chemoresistance. Therefore, early …

Mechanisms of taxane resistance

SM Maloney, CA Hoover, LV Morejon-Lasso… - Cancers, 2020 - mdpi.com
Simple Summary Drug resistance is prevalent in many types of cancer and decreases
patient survival. The taxanes are anti-mitotic chemotherapeutic agents, widely used since …

Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs

W Jiang, J Xia, S Xie, R Zou, S Pan, Z Wang… - Drug Resistance …, 2020 - Elsevier
Chemoresistance including intrinsic and acquired anticancer drug resistance continues to
be a primary hindrance towards curative cancer treatment. Therefore, deciphering the …

Non-coding RNAs in endometrial physiopathology

A La Ferlita, R Battaglia, F Andronico, S Caruso… - International journal of …, 2018 - mdpi.com
The Human Genome Project led to the discovery that about 80% of our DNA is transcribed in
RNA molecules. Only 2% of the human genome is translated into proteins, the rest mostly …

The prognostic value and mechanisms of lncRNA UCA1 in human cancer

F Yao, Q Wang, Q Wu - Cancer management and research, 2019 - Taylor & Francis
Long noncoding RNAs (lncRNAs), longer than 200 nucleotides in length, play important
roles in the development and progression of various cancers. An increasing number of …

LncRNA regulation: New frontiers in epigenetic solutions to drug chemoresistance

Y Zhou, W Sun, Z Qin, S Guo, Y Kang, S Zeng… - Biochemical …, 2021 - Elsevier
Long-noncoding RNAs (lncRNAs) have been shown to participate in sensitizing or de-
sensitizing cancer cells to chemical drugs during cancer therapeutics. Notably, a plethora of …